6 1/2 X 9 7/16 in 1. PPARs as therapeutic targets for treating diabetes and insulin resist ance
2. Genetic regulators of human obesity and diabetes
3. NF-kb, insulin resistance and the actions of salicylates4. Wnt signaling and C/EBPs role in adipogenesis
5. Regulation of hepatic gluconeogenesis C/EPBs
6. Forkhe ad proteins and regulation of hepatic gene expression
7. Co ntrol of mitochondrial biogenesis through PGC-1
8. Regulati on of PGC-1 in humans in insulin resistance and diabetes: Functional imp lications
9. FOXC2 controls resistance to obesity and Type II diabetes
10. SREB-1C regulation of nutrient homeostasis and lipid accumulation
11. GATA proteins as molecular gatek eeprs of the adipocyte
12. Diabetes regulation of gene expr ession by CREB
13. Molecular etiologies of MODY and other e arly-onset forms of diabetes
14. Liver X receptors as poten tial drug targets for Diabetes and its disorders
15. The po tential therapeutic use of PPAR beta/delta agonists in lipid and glucose